Brazilian seed industry seeks faster GMO regulatory alignment with China

Chinese approval shapes Brazilian seed launches

Brazil’s seed industry is calling for greater regulatory coordination with China on genetically modified crops, Globo Rural reported. A new transgenic variety intended for the Brazilian market also needs approval from Beijing because China is the principal destination for Brazilian soybeans. Without clearance in the largest customer market, commercial introduction could expose exporters to the risk that harvested grain contains a trait not authorized by the importing country.

The requirement links two otherwise separate decisions. Brazil evaluates whether a biotechnology product may be cultivated domestically, while China decides whether commodities containing that trait may enter its market. Seed developers therefore cannot treat Brazilian authorization alone as a sufficient basis for a large-scale launch when the resulting crop is likely to move through an export chain serving Chinese buyers.

The industry’s request for regulatory “synchronization” is aimed at narrowing the gap between those procedures. Faster or more closely coordinated reviews would give seed companies greater certainty over launch schedules and allow farmers to adopt new varieties without creating avoidable compliance problems for grain handlers, processors and exporters.

Governments discuss technical cooperation

The issue has also entered bilateral government talks. Brazil’s Ministry of Agriculture and Livestock said the two countries’ agriculture authorities met to discuss cooperation in agricultural biotechnology, including biosafety assessments, regulatory frameworks for genetically modified organisms and opportunities to align technical standards.

According to the ministry, Brazil’s National Technical Commission on Biosafety, known as CTNBio, oversees 24 regulations covering the biosafety of plants, animals, microorganisms and human health. Brazilian officials presented technical dialogue and gradual alignment as ways to support innovation, competitiveness and technology transfer while maintaining safety assessments.

CNN Brasil reported on 17 April 2025 that the Brazilian government was negotiating an agreement with China to share technical information and reduce bureaucracy in the approval of biotechnology products, including genetically modified seeds and gene-edited foods. The talks indicate that the bottleneck is not limited to one crop or company but affects the broader path from research to commercial use.

Export exposure raises the cost of delays

China’s role gives its approval calendar direct commercial importance in Brazil. Chinese officials cited by Brazil’s agriculture ministry described Brazil as a trusted supplier of soybeans and corn and said the countries had maintained a stable flow of genetically modified agricultural products. That trade relationship makes regulatory compatibility a condition for preserving access, not merely an administrative concern for seed developers.

Asynchronous approvals can divide the value chain. Seed companies may hold a Brazilian authorization but delay sales; farmers may have access to a new agronomic tool but be unable to plant it widely; and traders must prevent grain carrying an unapproved trait from entering cargoes bound for China. Segregation and traceability can reduce risk, but they also add operational demands across storage, processing and transport.

Closer alignment would not require either country to abandon its own biosafety review. The practical objective is earlier information exchange and more predictable sequencing of decisions. For Brazilian producers, the benefit would be quicker access to approved technology. For seed companies and exporters, it would reduce the period in which a product is legally available in Brazil but commercially constrained by the rules of its largest overseas market.